• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美国成人血友病患者中,使用疼痛、功能障碍和生活质量(P-FiQ)研究中的患者报告结局工具评估疼痛、功能障碍、焦虑和抑郁。

Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient-reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.

机构信息

University of Colorado School of Medicine, Aurora, CO, USA.

Wake Forest School of Medicine, Winston-Salem, NC, USA.

出版信息

Eur J Haematol. 2018 Apr;100 Suppl 1:5-13. doi: 10.1111/ejh.13027.

DOI:10.1111/ejh.13027
PMID:29498784
Abstract

INTRODUCTION

Pain, functional impairment, anxiety, and depression associated with joint disease may affect health-related quality of life (HRQoL) in people with hemophilia.

OBJECTIVE

To report detailed patient-reported outcomes (PRO) assessments related to HRQoL in participants in the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.

METHODS

Pain and HRQoL were assessed via PRO instruments in US adult males with hemophilia A or B and a history of joint pain or bleeding. PRO instruments included EQ-5D-5L with visual analog scale, Brief Pain Inventory v2 Short Form, SF-36v2, and Hemophilia Activities List. Instrument domain and item responses were described.

RESULTS

Responses were collected from 381 adult males with a median age of 34 years. Pain was observed across instruments and affected daily activities and quality of life. Respondents reported functional impairment that limited the kind of work and activities they participated in, with activities involving the lower extremities being most affected. A high prevalence of mental health disorders was identified across instruments.

CONCLUSIONS

Pain and HRQoL were evaluated using multiple PRO instruments, which vary in timescales of assessment and levels of detail. More consistent clinical assessments and patient dialog regarding pain and aspects of HRQoL may help drive improved outcomes.

摘要

简介

与关节疾病相关的疼痛、功能障碍、焦虑和抑郁可能会影响血友病患者的健康相关生活质量(HRQoL)。

目的

报告与 Pain,Functional Impairment,and Quality of Life(P-FiQ)研究中参与者的 HRQoL 相关的详细患者报告结局(PRO)评估。

方法

通过 PRO 工具评估美国成年男性血友病 A 或 B 患者的疼痛和 HRQoL,这些患者有过关节疼痛或出血史。PRO 工具包括 EQ-5D-5L 与视觉模拟量表、简短疼痛量表 v2 短表、SF-36v2 和血友病活动清单。描述了仪器域和项目的反应。

结果

从 381 名中位年龄为 34 岁的成年男性中收集了回复。疼痛在各种仪器上均有表现,影响日常活动和生活质量。受访者报告存在功能障碍,限制了他们参与的工作和活动类型,下肢活动受影响最大。在各种仪器上都发现了心理健康障碍的高患病率。

结论

使用多种 PRO 工具评估了疼痛和 HRQoL,这些工具在评估时间范围和详细程度上有所不同。更一致的临床评估和患者对疼痛和 HRQoL 方面的对话可能有助于改善结果。

相似文献

1
Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient-reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.在美国成人血友病患者中,使用疼痛、功能障碍和生活质量(P-FiQ)研究中的患者报告结局工具评估疼痛、功能障碍、焦虑和抑郁。
Eur J Haematol. 2018 Apr;100 Suppl 1:5-13. doi: 10.1111/ejh.13027.
2
What can we learn from using formal patient-reported outcome instruments to assess pain, functional impairment, anxiety, and depression in US adults with hemophilia?使用正式的患者报告结局工具评估美国血友病成人的疼痛、功能障碍、焦虑和抑郁,我们能从中得到什么启示?
Eur J Haematol. 2018 Apr;100 Suppl 1:3-4. doi: 10.1111/ejh.13026.
3
Patient-reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.美国不同特征血友病成人亚组的患者报告结局和关节状况:疼痛、功能障碍和生活质量(P-FiQ)研究结果。
Eur J Haematol. 2018 Apr;100 Suppl 1:14-24. doi: 10.1111/ejh.13028.
4
Factors associated with pain severity, pain interference, and perception of functional abilities independent of joint status in US adults with hemophilia: Multivariable analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.与美国血友病成人关节状况无关的疼痛严重程度、疼痛干扰和功能能力感知相关因素:疼痛、功能障碍和生活质量(P-FiQ)研究的多变量分析。
Eur J Haematol. 2018 Apr;100 Suppl 1:25-33. doi: 10.1111/ejh.13025.
5
Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study.美国血友病成人患者疼痛和功能障碍的影响:疼痛、功能障碍和生活质量(P-FiQ)研究中的患者报告结局和肌肉骨骼评估。
Haemophilia. 2018 Mar;24(2):261-270. doi: 10.1111/hae.13377. Epub 2017 Dec 8.
6
Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.美国成年血友病患者自我报告结局工具的结构效度:疼痛、功能障碍和生活质量(P-FiQ)研究结果
Patient Prefer Adherence. 2017 Aug 9;11:1369-1380. doi: 10.2147/PPA.S141390. eCollection 2017.
7
Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.血友病成人患者报告结局工具和血友病关节健康评分v2.1在美国成年人中的已知组效度:疼痛、功能障碍和生活质量(P-FiQ)研究结果
Patient Prefer Adherence. 2017 Oct 11;11:1745-1753. doi: 10.2147/PPA.S141392. eCollection 2017.
8
Impact of hemophilia B on quality of life in affected men, women, and caregivers-Assessment of patient-reported outcomes in the B-HERO-S study.血友病 B 对患病男性、女性及其照护者生活质量的影响——B-HERO-S 研究中患者报告结局的评估。
Eur J Haematol. 2018 Jun;100(6):592-602. doi: 10.1111/ejh.13055. Epub 2018 Apr 11.
9
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.美国成年血友病患者自我报告结局工具及血友病关节健康评分v2.1的内部一致性和项目-总分相关性:疼痛、功能障碍和生活质量(P-FiQ)研究结果
Patient Prefer Adherence. 2017 Oct 25;11:1831-1839. doi: 10.2147/PPA.S141391. eCollection 2017.
10
Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study.美国成年血友病患者自我报告结局工具的可靠性:疼痛、功能障碍与生活质量(P-FiQ)研究
Patient Prefer Adherence. 2017 Sep 19;11:1603-1612. doi: 10.2147/PPA.S141389. eCollection 2017.

引用本文的文献

1
Clinical Burden and Healthcare Resource Use Among Adults Living with Hemophilia A: An Observational Study.血友病A成年患者的临床负担与医疗资源利用:一项观察性研究
Drugs Real World Outcomes. 2025 Sep 1. doi: 10.1007/s40801-025-00516-8.
2
The association between unemployment and treatment among adults with hemophilia.成年血友病患者的失业与治疗之间的关联。
Res Pract Thromb Haemost. 2024 Jul 14;8(5):102514. doi: 10.1016/j.rpth.2024.102514. eCollection 2024 Jul.
3
The Classification of Suspected Predominant Nociplastic Pain in People with Moderate and Severe Haemophilia: A Secondary Exploratory Study.
中重度血友病患者疑似主要伤害感受性疼痛的分类:一项二次探索性研究。
Biomedicines. 2023 Sep 7;11(9):2479. doi: 10.3390/biomedicines11092479.
4
Work participation in adults with rare genetic diseases - a scoping review.罕见遗传病成人的工作参与情况——范围综述。
BMC Public Health. 2023 May 19;23(1):910. doi: 10.1186/s12889-023-15654-3.
5
Racial and Ethnic Differences in Distress, Depression, and Quality of Life in people with hemophilia.血友病患者的痛苦、抑郁和生活质量的种族和民族差异。
J Racial Ethn Health Disparities. 2024 Jun;11(3):1394-1404. doi: 10.1007/s40615-023-01616-3. Epub 2023 May 3.
6
High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study.血友病患者中止痛、抗抑郁和抗焦虑药物的高使用率:一项针对北欧11年登记数据的研究,涉及3000多名血友病患者。
Res Pract Thromb Haemost. 2023 Jan 31;7(2):100061. doi: 10.1016/j.rpth.2023.100061. eCollection 2023 Feb.
7
Decline in health-related quality of life and foot and ankle patient reported outcomes measures in patients with haemophilia and ankle haemarthropathy.血友病伴踝关节关节病患者健康相关生活质量和足踝关节患者报告结局测量指标下降。
J Foot Ankle Res. 2023 Mar 10;16(1):12. doi: 10.1186/s13047-023-00611-5.
8
Gene therapy for hemophilia: looking beyond factor expression.血友病的基因治疗:超越因子表达。
Exp Biol Med (Maywood). 2022 Dec;247(24):2223-2232. doi: 10.1177/15353702221147565. Epub 2023 Jan 23.
9
Long-term prophylaxis: what are our options and how to define success?长期预防:我们有哪些选择,如何定义成功?
Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):579-585. doi: 10.1182/hematology.2022000397.
10
Cost-effectiveness of recombinant factor VIII Fc versus emicizumab for prophylaxis in adults and adolescents with haemophilia A without inhibitors in the UK.在英国,对于无抑制剂的血友病 A 成人和青少年患者,重组凝血因子 VIII Fc 与emicizumab 预防治疗的成本效益比较。
Eur J Haematol. 2023 Mar;110(3):262-270. doi: 10.1111/ejh.13901. Epub 2022 Dec 11.